emrusolmin

AssetSmall moleculeAlso TEV-56286

Inhibits alpha-synuclein aggregation and misfolding.

Stage
Phase 2
Modality
Small molecule
Target
SNCA
Indications
1
Trials
1
Developers
1

Indications

1
  • Targets and what it contains2
  • Owner and partners1
  • Trials1
  • Evidence for its targets2
  • Competitors8
  • Aging relevance1
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 1 source

Assets